Regulatory report: Cannabis is a narcotic substance in Hungary

Description

CBD is not a controlled substance in Hungary, and the authority that is responsible for CBD-related products depends entirely on their intended purpose. This report covers a wide range of aspects including hemp cultivation and disposal, extracts and finished products, imports and exports, and medical and recreational cannabis, including the numerous laws and relevant bodies that are involved in the enforcement and regulation of each.

CBD-Intel does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CBD-Intel, does not accept any liability or responsibility for information or views published.

New report guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new report for free.

Reasons to buy

This report will provide you with a deeper understanding of the current regulatory landscape in Hungary. The country takes an especially tough stance on cannabis, with no indication of the possibility of a medical cannabis programme being introduced, as is the case for many other EU countries. This report will enable you to obtain a detailed knowledge of all aspects of Hungary’s CBD regime.

Table of contents

Executive summary

Hemp plant

Cultivation
Strains
THC
Disposal
Processing

Extracts as a consumer product

CBD isolates
Full spectrum
Flowers

Finished product

Food
Food supplements
Cosmetic products
Vaping products
Pet food

Import/export

Hemp
CBD/full spectrum
Finished products

Medical and recreational cannabis

Relevant regulation

Relevant bodies

Methodology

The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including: online and offline resources and data, specialised legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground profession.